Literature DB >> 15944914

Localization of annexins I, II, IV and VII in whole prostate sections from radical prostatectomy patients.

U Lehnigk1, U Zimmermann, C Woenckhaus, J Giebel.   

Abstract

Annexins (ANXs) represent a family of calcium and phospholipid binding proteins that are involved in several physiological processes e.g. signal transduction, cellular differentiation and proliferation. Since they are known to be dysregulated in a variety of cancers we investigated the immunolocalization of ANXs in whole prostate sections containing benign prostatic epithelium (BPE), benign prostatic hyperplasia (BPH), prostatic intraepithelial neoplasia (PIN) and prostate cancer (PCa) in order to evaluate their possible role during tumorigenesis. Samples were obtained from 28 patients undergoing radical prostatectomy. Gross sections of whole prostates were examined immunohistochemically for the distribution of ANX I, II, IV and VII. In BPE all ANXs were localized to the cell membranes and the cytoplasm of all gland cells. In BPH the immunoreactivity of ANX I and II was restricted to the basal cells of glands and expression pattern of ANX IV and VII was similar to BPE. In PIN only basal cells expressed ANX II. In PCa ANX II immunoreactivity was absent and weak ANX I and ANX IV immunoreactivity was restricted to the cytoplasm of tumor cells. ANX VII immunoreactivity was seen in some but not all tumor cells. Since ANX IV and VII expression did not show significant changes in PCa compared to non-neoplastic tissue and PIN an essential role during prostate tumourigenesis seems unlikely. In contrast, as progression from PIN to PCa is characterized by a reduction of ANX I and II this suggests that downregulation of these proteins could represent an important event in prostate carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15944914     DOI: 10.14670/HH-20.673

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  7 in total

1.  [Research in urologic university clinics. Assessment of current status and perspectives].

Authors:  K Miller; H Krause
Journal:  Urologe A       Date:  2006-09       Impact factor: 0.639

Review 2.  Proteomic research progress in lymphatic metastases of cancers.

Authors:  Junwei Zong; Chunmei Guo; Shuqing Liu; Ming-Zhong Sun; Jianwu Tang
Journal:  Clin Transl Oncol       Date:  2012-01       Impact factor: 3.405

3.  Comparison of annexin II, p63 and alpha-methylacyl-CoA racemase immunoreactivity in prostatic tissue: a tissue microarray study.

Authors:  Jocelyn Stewart; Neil Fleshner; Heather Cole; Joan Sweet
Journal:  J Clin Pathol       Date:  2006-08-17       Impact factor: 3.411

4.  Clinicopathological pattern and Annexin A2 and Cdc42 status in patients presenting with differentiation and lymphnode metastasis of esophageal squamous cell carcinomas.

Authors:  Jun-Guo Feng; Qing Liu; Xu Qin; Yue-Hua Geng; Shu-Tao Zheng; Tao Liu; Ilyar Sheyhidin; Xiao-Mei Lu
Journal:  Mol Biol Rep       Date:  2011-05-21       Impact factor: 2.316

5.  The role of annexins I, II and IV in tumor development, progression and metastasis of human penile squamous cell carcinomas.

Authors:  C Protzel; M Richter; M Poetsch; C Kakies; U Zimmermann; C Woenckhaus; K J Klebingat; O W Hakenberg; J Giebel
Journal:  World J Urol       Date:  2010-07-03       Impact factor: 4.226

6.  The association of annexin A2 and cancers.

Authors:  Xiaohui Zhang; Shuqing Liu; Chunmei Guo; Junwei Zong; Ming-Zhong Sun
Journal:  Clin Transl Oncol       Date:  2012-07-24       Impact factor: 3.405

7.  Annexin A1 is involved in the acquisition and maintenance of a stem cell-like/aggressive phenotype in prostate cancer cells with acquired resistance to zoledronic acid.

Authors:  Valentina Bizzarro; Raffaella Belvedere; Maria Rita Milone; Biagio Pucci; Rita Lombardi; Francesca Bruzzese; Ada Popolo; Luca Parente; Alfredo Budillon; Antonello Petrella
Journal:  Oncotarget       Date:  2015-09-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.